Upload Avatar (500 x 500)
Lu Weiyue
Pharmaceutical Sciences
Fudan University
Shanghai
Language: Chinese, English
Drug Delivery
Nanomedicine
Targeted Therapy
Blood-Brain Barrier
Glioblastoma
Peptide Ligands
Nanoparticles
Chemotherapy
Gene Therapy
Pharmaceutics
Areas of Focus
- Drug Targeting Strategies and Novel Drug Delivery Systems
Work Experience
- 1982.07 – Present: Various roles at Shanghai Medical University (now Fudan University), including Assistant, Lecturer, Associate Professor, and Professor in the Department of Pharmaceutics
- 1995.03 – Present: Master's and Doctoral Supervisor in Pharmaceutics, Fudan University
- 1997.03 – 2018.07: Various administrative roles at Fudan University, including Deputy Director of the Institute of Pharmacy, Vice Dean, Executive Vice Dean, and Party Secretary
- 2009.01 – Present: Leader of the National Key Discipline of Pharmaceutics at Fudan University, Director of the Key Laboratory of Intelligent Drug Delivery, Ministry of Education, Chief Scientist of the '973' Project
Academic Background & Achievements
- 1978.09 – 1982.07 Bachelor: Shanghai First Medical College, Department of Pharmacy
- 2005.09 – 2013.12 PhD: Shanghai Institute of Pharmaceutical Industry, Pharmaceutics (under Academician Hou Huimin)
- Fudan University Distinguished Professor
- First Director of the National Key Laboratory of Advanced Drug Delivery Systems
- Leader of the National Key Discipline of Pharmaceutics at Fudan University
- Chief Scientist of the '973' Project
- National Excellent Doctoral Dissertation Advisor
- First Director of the Key Laboratory of Intelligent Drug Delivery, Ministry of Education and the Military
- Recipient of the State Council Special Government Allowance
Publications
- Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs, Lu Weiyue, 2023
- All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals, Lu Weiyue, 2022
- Engineered platelets-based drug delivery platform for targeted thrombolysis, Lu Weiyue, 2022
- Facile separation of PEGylated liposomes enabled by anti-PEG scFv, Lu Weiyue, 2021
- A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated, Lu Weiyue, 2021
- Stapled RAP12 Peptide Ligand of LRP1 for Micelles-based Multifunctional Glioma-Targeted Drug Delivery, Lu Weiyue, 2021
- All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide, Lu Weiyue, 2020
- Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma, Lu Weiyue, 2020
- Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma, Lu Weiyue, 2019
- Liposomes with cyclic RGD peptide motif triggers acute, immune response in mice, Lu Weiyue, 2019
Awards
- 2017: Chinese Medical Science and Technology Award, Second Prize (Participant)
- 2016: Ministry of Education Natural Science Award, Second Prize (Host)
- 2016: Shanghai Natural Science Award, Second Prize (Host)
- 2014: Chinese Pharmaceutical Association Science and Technology Award, Second Prize (Host)
- 2013: Chinese Medical Science and Technology Award, Third Prize (Participant)
- 2009: Shanghai Pharmaceutical Science and Technology Award, Second Prize (Host)
- 2008: Chinese Medical Science and Technology Award, Third Prize; Ministry of Education Science and Technology Progress Award, Second Prize; Shanghai Science and Technology Award, Third Prize (Participant)
- 2014: Shanghai Talent Award
- 2013: National Excellent Doctoral Dissertation Advisor
- 2012: National Excellent Doctoral Dissertation Advisor
- 2003: Fudan University Pukang Award
- 2001: Xu Guangqi Science and Technology Medal Gold Award
- 2000: Meiji Dairy Life Science Award
- 2000: Baosteel Excellent Teacher Award
